Global HIV Diagnostics Market Size Study & Forecast by Product (Consumables, Instruments), Mode (Self-test), Test Type and End Use, and Regional Forecasts 2022-2032

The Global HIV Diagnostics Market was valued at approximately USD 1.13 billion in 2024 and is projected to expand at a steady CAGR of around 5.00% throughout the forecast period from 2025 to 2035. HIV diagnostics encompass a comprehensive range of technologies and tests designed to detect the presence of the Human Immunodeficiency Virus in individuals, facilitating early diagnosis, monitoring, and management of the disease. The market’s upward trajectory is propelled by increasing awareness, widespread government initiatives, and heightened demand for rapid and accurate testing methods. Furthermore, the rising prevalence of HIV infections worldwide, coupled with advances in diagnostic techniques, significantly bolsters the market growth prospects. The integration of cutting-edge technologies such as molecular diagnostics and self-testing kits is also reshaping the landscape, enhancing accessibility and convenience for users globally.

The growing emphasis on early detection to curb the transmission of HIV infections has led to the accelerated adoption of innovative diagnostic tools and consumables, which are indispensable in healthcare settings. According to UNAIDS, approximately 38 million people globally were living with HIV in 2023, highlighting an urgent need for scalable diagnostic solutions. Moreover, the increasing prevalence of HIV in low- and middle-income countries, combined with supportive government funding and NGO interventions, is driving substantial demand for cost-effective and easy-to-use diagnostic products. Despite some challenges such as regulatory hurdles and concerns over the accuracy of rapid tests, ongoing technological advancements and product launches are expected to overcome these barriers, offering lucrative opportunities for market players.

Geographically, North America holds a dominant position in the HIV diagnostics market, attributed to its advanced healthcare infrastructure, high healthcare expenditure, and strong presence of key market players engaged in research and development. The United States leads the regional market, benefiting from extensive HIV screening programs and widespread adoption of self-testing devices. Europe follows closely, with increasing government initiatives aimed at reducing HIV incidence and enhanced reimbursement policies fostering market growth. Meanwhile, the Asia Pacific region is anticipated to emerge as the fastest-growing market due to escalating HIV awareness campaigns, rising healthcare infrastructure investments, and expanding access to diagnostic technologies in countries such as India and China. The Latin America and Middle East & Africa regions are also witnessing gradual market expansion owing to increasing collaborations between governments and international health organizations.

Major market players included in this report are:
• Halliburton Company
• Schlumberger Limited
• Croda International Plc.
• Baker Hughes Company
• Chevron Phillips Chemical Company
• BASF SE
• M&D Industries Of Louisiana, Inc.
• Trican Well Service Ltd.
• Aubin Group
• Impact Fluid Solutions
• Abbott Laboratories
• Roche Diagnostics
• Siemens Healthineers
• Bio-Rad Laboratories
• Becton, Dickinson and Company

Global HIV Diagnostics Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period – 2025-2035
• Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segments of the market are explained below:

By Product:
• Consumables
• Instruments

By Mode:
• Self-test

By Test Type:
• (Not further segmented here, but included as a key segment)

By End Use:
• (Not further segmented here, but included as a key segment)

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe (ROE)

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific (RoAPAC)

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more